PT - JOURNAL ARTICLE AU - L. Kristen AU - Fei Liu TI - Auto tuning SIR model parameters using genetic algorithm AID - 10.1101/2021.07.19.21260722 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.19.21260722 4099 - http://medrxiv.org/content/early/2021/07/24/2021.07.19.21260722.short 4100 - http://medrxiv.org/content/early/2021/07/24/2021.07.19.21260722.full AB - Earlier studies [1] comparing Covid-19 simulations using extended SIR model [2] with observed new cases in New Jersey and United States showed good agreement between simulated results and observational data. The parameters of the SIR model controlling the behavior of the model have to be manually adjusted until the modelled results and observations reach good agreement. The parameter tuning process is tedious and time consuming. In this work, we have developed an approach using genetic algorithm [3] to automatically select the most optimal set of parameters to minimize the residual between simulated result and observational data. The parameter tuning process applying SIR model can now be automated without tedious and time consuming manual intervention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding for the work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work does not involve clinical trials and therefore the IRB/ethics committee approval is not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the study are in public domain and can be accessed at https://github.com/CSSEGISandData/COVID-19 https://github.com/CSSEGISandData/COVID-19